Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Debt to Equity (2020)

Historic Debt to Equity for Foghorn Therapeutics (FHTX) over the last 1 years, with Q4 2020 value amounting to $0.13.

  • Foghorn Therapeutics' Debt to Equity changed N/A to $0.13 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.13, marking a year-over-year change of. This contributed to the annual value of $0.13 for FY2020, which is N/A changed from last year.
  • Per Foghorn Therapeutics' latest filing, its Debt to Equity stood at $0.13 for Q4 2020.
  • In the past 5 years, Foghorn Therapeutics' Debt to Equity registered a high of $0.13 during Q4 2020, and its lowest value of -$0.11 during Q3 2020.